This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated TYK2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TYK2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~133.7 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Caudate (IHC candidate; verify WB) |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A01642-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human small intestine tissue lysate (catalog A01642-1) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A01642-1 · (A) 1 and (B) 2 μg/mL (catalog A01642-1) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
Full-length TYK2 is predicted at 133.7 kDa; phosphorylation may affect migration, but no empirical band or visible shift is established.
| Single band near 133.7 kDa | Consistent with predicted full-length TYK2; confirm its identity |
| Close doublet near 133.7 kDa | Could reflect TYK2 phosphorylation states, though a visible shift is unestablished |
| Several nearby bands | Could include different TYK2 phosphorylation states; confirm each band's identity |
| No band near 133.7 kDa | TYK2 was not detected at its predicted position; absence is unproven |
| UniProt predicted mass | Places full-length TYK2 near 133.7 kDa; apparent migration is unestablished |
| Phosphotyrosine at residue 292 | May affect migration, but no visible shift is demonstrated |
| Phosphoserine at residue 499 | May affect migration, but no visible shift is demonstrated |
| Phosphotyrosine at residue 1054 | May affect migration, but no visible shift is demonstrated |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | TYK2 may be below detection or antibody binding may be inadequate | Check loading and antibody performance with a validated positive control |
| Band higher than expected | Band identity and reason for slower migration are unestablished | Compare with a validated TYK2 control and confirm with a second antibody |
| Band lower than expected | Proteolysis or an unrelated band is possible | Use fresh lysate with protease inhibitors and confirm with a second antibody |
| Multiple bands | TYK2 phosphorylation states are possible, but other bands may be unrelated | Compare phosphatase-treated and untreated lysates with appropriate controls |
| Weak or no signal | TYK2 signal may be below detection | Check sample loading and use a validated positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | neuropil | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
| Hippocampus | glial cells | Not detected | Protein (IHC) | HPA → |
| Lymph node | germinal center cells | Not detected | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Low | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for TYK2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports two anti-TYK2 antibodies with WB images: A01642-1 in human small intestine lysate at 1–2 μg/mL, and A01642-3 in human MCF-7 and HeLa lysates at 0.5 μg/mL, with a reported 134 kDa band. The images show human samples only.
Which to pick: Choose A01642-1 if catalogued mouse or rat reactivity matters, though its WB image uses human tissue. For human cell lysates, A01642-3 has images using MCF-7 and HeLa. Neither caption demonstrates mouse or rat WB.